发明名称 Aminoguanidine derivatives.
摘要 A aminoguanidine derivatives of the general formula: <CHEM> (wherein, R<1b> represents a hydrogen atom, alkyl group of from 1 to 6 carbon atom(s), cycloalkyl group of from 5 to 7 carbon atoms or carbocyclic or heterocyclic ring unsubstituted or substituted by from one to three halogen atom(s), alkyl group(s) of from 1 to 4 carbon atom(s), alkoxy group(s) of from 1 to 4 carbon atom(s) or nitro group, Xb represents a bond, alkylene group of from 1 to 4 carbon atom(s) or alkenylene group of from 2 to 4 carbon atoms, R<2b> represents a hydrogen atom, alkyl group of from 1 to 6 carbon atom(s) or phenyl group, R<3b> represents a hydrogen atom, phenyl group, alkyl group of from 1 to 4 carbon atom(s), phenylalkyl group of from 7 to 10 carbon atoms or pyridyl group <CHEM> represents a heterocyclic ring, which contains nitrogen atom or one nitrogen and one oxygen atom, of from 3 to 10 carbon atoms unsubstituted or substituted by a hydroxy group. With the proviso that the compounds wherein R<2b> represents a hydrogen atom, -Xb-R<1b> represents a hydrogen atom, methyl group, ethyl group or phenyl group and R<3b> represents a hydrogen atom or methyl group, are excluded.) or acid addition salt thereof possess inhibitory activity on Maillard reaciton, and therefore is useful for treating and/or prevention of several diabetic complications and diseases induced by aging.
申请公布号 EP0339496(A2) 申请公布日期 1989.11.02
申请号 EP19890107168 申请日期 1989.04.20
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 OHUCHIDA, SHUICHI ONO PHARMACEUTICAL CO., LTD.;TODA, MASAAKI ONO PHARMACEUTICAL CO., LTD.;MIYAMOTO, TSUMORU ONO PHARMACEUTICAL CO., LTD.
分类号 A61K31/34;A61K31/341;A61K31/4402;A61K31/445;A61K31/47;A61K31/472;A61P3/08;A61P3/10;A61P9/00;A61P43/00;C07C281/16;C07D211/06;C07D211/46;C07D213/75;C07D213/77;C07D217/06;C07D295/215;C07D307/52;C07D295/20 主分类号 A61K31/34
代理机构 代理人
主权项
地址